Hypokalemia and outcomes in patients with chronic heart failure and chronic kidney disease findings from propensity-matched studies

Circulation: Heart Failure

Volumn 3, Issue 2, 2010, Pages 253-260

  Bowling, C Barrett ^a,c   Pitt, Bertram ^e   Ahmed, Mustafa I ^d   Aban, Inmaculada B ^c   Sanders, Paul W ^b,c   Mujib, Marjan ^c   Campbell, Ruth C ^c   Love, Thomas E ^f   Aronow, Wilbert S ^g   Allman, Richard M ^c   Bakris, George L ^h   Ahmed, Ali ^a,b,c,d  

^a Section of Geriatrics   (United States)

^b BIRMINGHAM VA MEDICAL CENTER   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d University of Alabama at Birmingham   (United States)

^e UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^f CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g NEW YORK MEDICAL COLLEGE   (United States)

^h UNIVERSITY OF CHICAGO   (United States)

Author keywords

Chronic kidney disease; Heart failure; Hospitalization; Hypokalemia; Mortality; Propensity score

Indexed keywords

DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; POTASSIUM; POTASSIUM SPARING DIURETIC AGENT;

AGE; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG USE; FEMALE; GENDER; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITALIZATION; HUMAN; HYPOKALEMIA; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; RISK ASSESSMENT; BLOOD; CANADA; CAUSE OF DEATH; CHI SQUARE DISTRIBUTION; CHRONIC DISEASE; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HEART FAILURE; NONPARAMETRIC TEST; PROPORTIONAL HAZARDS MODEL; RANDOMIZED CONTROLLED TRIAL; STATISTICS; UNITED STATES;

AGED; CANADA; CAUSE OF DEATH; CHI-SQUARE DISTRIBUTION; CHRONIC DISEASE; FEMALE; GLOMERULAR FILTRATION RATE; HEART FAILURE; HOSPITALIZATION; HUMANS; HYPOKALEMIA; KIDNEY FAILURE, CHRONIC; MALE; PROPORTIONAL HAZARDS MODELS; STATISTICS, NONPARAMETRIC; UNITED STATES;

EID: 77951911801     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.109.899526     Document Type: Article

References (45)

1. Ahmed A, Zannad F, Love TE, Tallaj J, Gheorghiade M, Ekundayo OJ, Pitt B. A propensity-matched study of the association of low serum potassium levels and mortality in chronic heart failure. Eur Heart J. 2007;28:1334-1343.
2. Alper AB, Campbell RC, Anker SD, Bakris G, Wahle C, Love TE, Hamm LL, Mujib M, Ahmed A. A propensity-matched study of low serum potassium and mortality in older adults with chronic heart failure. Int J Cardiol. 2009;137:1-8.
3. Ahmed A, Rich MW, Sanders PW, Perry GJ, Bakris GL, Zile MR, Love TE, Aban IB, Shlipak MG. Chronic kidney disease associated mortality in diastolic versus systolic heart failure: a propensity matched study. Am J Cardiol. 2007;99:393-398.
4. The National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39: S1-S266.
5. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med. 1997;336:525-533.
6. Ahmed MI, Ekundayo OJ, Mujib M, Campbell RC, Sanders PW, Pitt B, Perry GJ, Bakris G, Aban I, Love TE, Aronow WS, Ahmed A. Mild hyperkalemia and outcomes in chronic heart failure: a propensity matched study. Int J Cardiol [Epub ahead of print].
7. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461-470.
8. Archibald G, Bartlett W, Brown A, Christie B, Elliott A, Griffith K, Pound S, Rappaport I, Robertson D, Semple Y, Slane P, Whitworth C, Williams B. UK Consensus Conference on early chronic kidney disease-6 and 7 February 2007. Nephrol Dial Transplant. 2007;22:2455-2457.
9. Macdonald JE, Struthers AD. What is the optimal serum potassium level in cardiovascular patients? J Am Coll Cardiol. 2004;43:155-161.
10. Collins JF, Howell CL, Horney RA; Digitalis Investigation Group Investigators. Determination of vital status at the end of the DIG trial. Control Clin Trials. 2003;24:726-730.
11. Rosenbaum PR, Rubin DB. Constructing a control group using multivariate matched: sampling methods that incorporate the propensity score. Am Stat. 1985;39:33-38.
12. Rubin DB. Using propensity score to help design observational studies: application to the tobacco litigation. Health Serv Outcomes Res Methodol. 2001;2:169-188.
13. Austin PC. Primer on statistical interpretation or methods report card on propensity-score matching in the cardiology literature from 2004 to 2006: a systematic review. Circ Cardiovasc Qual Outcomes. 2008;1:62-67.
14. Fitzmaurice G. Confounding: regression adjustment. Nutrition. 2006;22:581-583.
15. D'Agostino RB Jr. Propensity scores in cardiovascular research. Circulation. 2007;115:2340-2343.
16. Ahmed A, Husain A, Love TE, Gambassi G, Dell'Italia LJ, Francis GS, Gheorghiade M, Allman RM, Meleth S, Bourge RC. Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods. Eur Heart J. 2006;27:1431-1439.
17. Adamopoulos C, Pitt B, Sui X, Love TE, Zannad F, Ahmed A. Low serum magnesium and cardiovascular mortality in chronic heart failure: a propensity-matched study. Int J Cardiol. 2009;136:270-277.
18. Ahmed A, Young JB, Love TE, Levesque R, Pitt B. A propensity-matched study of the effects of chronic diuretic therapy on mortality and hospitalization in older adults with heart failure. Int J Cardiol. 2008;125:246-253. (Pubitemid 351400220)
19. Ekundayo OJ, Adamopoulos C, Ahmed MI, Pitt B, Young JB, Fleg JL, Love TE, Sui X, Perry GJ, Siscovick DS, Bakris G, Ahmed A. Oral potassium supplement use and outcomes in chronic heart failure: a propensity-matched study. Int J Cardiol [Epub ahead of print].
20. Ekundayo OJ, Dell'Italia LJ, Sanders PW, Arnett D, Aban I, Love TE, Filippatos G, Anker SD, Lloyd-Jones DM, Bakris G, Mujib M, Ahmed A. Association between hyperuricemia and incident heart failure among older adults: a propensity-matched study. Int J Cardiol [Epub ahead of print].
21. Ritchie C, Ekundayo OJ, Muchimba M, Campbell RC, Frank SJ, Liu B, Aban IB, Ahmed A. Effects of diabetes mellitus in patients with heart failure and chronic kidney disease: a propensity-matched study of multimorbidity in chronic heart failure. Int J Cardiol. 2009;134:330-335.
22. Sui X, Gheorghiade M, Zannad F, Young JB, Ahmed A. A propensity matched study of the association of education and outcomes in chronic heart failure. Int J Cardiol. 2008;129:93-99.
23. D'Agostino RB Jr, D'Agostino RB Sr. Estimating treatment effects using observational data. J Am Med Assoc. 2007;297:314-316.
24. D'Agostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med. 1998;17:2265-2281.
25. Normand ST, Landrum MB, Guadagnoli E, Ayanian JZ, Ryan TJ, Cleary PD, McNeil BJ. Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: a matched analysis using propensity scores. J Clin Epidemiol. 2001;54:387-398.
26. Rosenbaum PR. Sensitivity to hidden bias. In: Rosenbaum PR, ed. Observational Studies. 2nd ed. New York: Springer-Verlag; 2002:110-124.
27. SPSS for Windows, Release Version 15 [Computer Program]. Chicago, Ill: SPSS Inc; 2009.
28. Eshaghian S, Horwich TB, Fonarow GC. Relation of loop diuretic dose to mortality in advanced heart failure. Am J Cardiol. 2006;97:1759-1764.
29. Francis GS, Siegel RM, Goldsmith SR, Olivari MT, Levine TB, Cohn JN. Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure: activation of the neurohumoral axis. Ann Intern Med. 1985;103:1-6.
30. Fitzovich DE, Hamaguchi M, Tull WB, Young DB. Chronic hypokalemia and the left ventricular responses to epinephrine and preload. J Am Coll Cardiol. 1991;18:1105-1111.
31. Shapiro JI, Banerjee A, Reiss OK, Elkins N. Acute and chronic hypokalemia sensitize the isolated heart to hypoxic injury. Am J Physiol. 1998;274: H1598-H1604.
32. Yano K, Hirata M, Matsumoto Y, Hano O, Mori M, Ahmed R, Mitsuoka T, Hashiba K. Effects of chronic hypokalemia on ventricular vulnerability during acute myocardial ischemia in the dog. Jpn Heart J. 1989;30:205-217.
33. Srivastava TN, Young DB. Impairment of cardiac function by moderate potassium depletion. J Card Fail. 1995;1:195-200.
34. Young DB, Lin H, McCabe RD. Potassium's cardiovascular protective mechanisms. Am J Physiol. 1995;268: R825-R837.
35. Silvestre JS, Heymes C, Oubenaissa A, Robert V, Aupetit-Faisant B, Carayon A, Swynghedauw B, Delcayre C. Activation of cardiac aldosterone production in rat myocardial infarction: effect of angiotensin II receptor blockade and role in cardiac fibrosis. Circulation. 1999;99:2694-2701.
36. Brilla CG, Matsubara LS, Weber KT. Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism. J Mol Cell Cardiol. 1993;25:563-575.
37. Kafka H, Langevin L, Armstrong PW. Serum magnesium and potassium in acute myocardial infarction: influence on ventricular arrhythmias. Arch Intern Med. 1987;147:465-469.
38. Cooper WD, Kuan P, Reuben SR, VandenBurg MJ. Cardiac arrhythmias following acute myocardial infarction: associations with the serum potassium level and prior diuretic therapy. Eur Heart J. 1984;5:464-469.
39. Nordrehaug JE, von der Lippe G. Serum potassium concentrations are inversely related to ventricular, but not to atrial, arrhythmias in acute myocardial infarction. Eur Heart J. 1986;7:204-209.
40. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW, Antman EM, Smith SC Jr, Adams CD, Anderson JL, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B; American College of Cardiology; American Heart Association Task Force on Practice Guidelines; American College of Chest Physicians; International Society for Heart and Lung Transplantation; Heart Rhythm Society. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (writing committee to update the 2001 guidelines for the evaluation and management of heart failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation. 2005;112: e154-e235.
41. Smilde TD, van Veldhuisen DJ, Navis G, Voors AA, Hillege HL. Drawbacks and prognostic value of formulas estimating renal function in patients with chronic heart failure and systolic dysfunction. Circulation. 2006;114:1572-1580.
42. Brown MJ, Brown DC, Murphy MB. Hypokalemia from β2-receptor stimulation by circulating epinephrine. N Engl J Med. 1983;309:1414-1419.
43. Lim M, Linton RA, Wolff CB, Band DM. Propranolol, exercise, and arterial plasma potassium. Lancet. 1981;2:591.
44. Rosa RM, Silva P, Young JB, Landsberg L, Brown RS, Rowe JW, Epstein FH. Adrenergic modulation of extrarenal potassium disposal. N Engl J Med. 1980;302:431-434.
45. Zebrack JS, Munger M, Macgregor J, Lombardi WL, Stoddard GP, Gilbert EM. Beta-receptor selectivity of carvedilol and metoprolol succinate in patients with heart failure (SELECT trial): a randomized doseranging trial. Pharmacotherapy. 2009;29:883-890.